November 22, 2013

On Nov. 18, the Senate passed by voice vote the Drug Quality and Security Act, sending to president Barack Obama's desk legislation that implements federal tracking and tracing of drugs and strengthens federal regulations on pharmacy compounding.

The bipartisan bill, which has the support of such trade groups as the National Association of Chain Drug Stores, the National Community Pharmacists Association and the Generic Pharmaceutical Association, ties up a couple of problematic loose ends in the pharmaceutical supply chain, namely the so-called "downstream" supply chain, which refers to the path that drugs take from their manufacturers to providers and patients, as well as sterile compounding.

September 27, 2013

Congress is expected to pass the Drug Quality and Security Act, which would subject sterile compounding pharmacies to stronger federal regulations and has attracted support from an independent pharmacy trade group, compared with a previous effort at federal regulations of compounding, Senate Bill 959, which many pharmacists feared would threaten their businesses and patients' access to compounded drugs. The efforts to place compounding pharmacies under federal regulations stem from last year's scandal in which many patients died and more were sickened after taking injected steroids contaminated with fungus.

The bills' purpose is simple enough: protecting the safety of patients by preventing irresponsible pharmacies like the New England Compounding Center from slipping through the cracks. But the older bill attracted opposition from independent pharmacies because, despite its good intentions, forced them to make costly changes to their business models or force them out of compounding altogether.

September 25, 2013

A bill under consideration by the Senate could force more than 40% of compounding pharmacies to abandon compounding, according to a new survey.

March 22, 2013

The commissioner of the Food and Drug Administration is renewing calls for legislation to give the agency more authority to regulate pharmacy compounding.

November 15, 2012

As the U.S. Senate and House of Representatives examined the meningitis outbreak this week, the National Association of Chain Drug Stores distinguished between the types of pharmacy compounding and the settings in which they take place, and emphasized the critical, life-saving benefits of pharmacy compounding.

November 2, 2012

Given the extent of the meningitis outbreak linked to a compounding pharmacy in Massachusetts, new regulations for such pharmacies might be a good idea, but how to implement them remains uncertain.

(THE NEWS: Meningitis outbreak linked to compounding pharmacy spawns new proposed legislation. Click here to read the story.)

July 30, 2012

How can Congress plug the leaks in the pharmaceutical supply chain and dry up the stream of gray market drugs without making the current drug shortage even worse? And can federal regulators shut down gray market profiteers without limiting “the ability of pharmacies to take care of their patients?”

May 23, 2012

Are the nation’s more than 330,000 pharmacy technicians ready to step up to a higher level of patient services and a more demanding but rewarding career? For most pharmacy techs, that step up in duties is either fast approaching or has already begun.

August 19, 2011

Asteres, a provider of 24/7 automated pharmacy kiosks, earlier this week announced that Guthrie Health is the first hospital pharmacy to offer OTC products in addition to prescriptions at their ScriptCenter kiosk.

September 21, 2010

Independent pharmacies have garnered the highest customer satisfaction scores among its competitors, according to results...

June 4, 2009

The news that Supervalu’s Jewel-Osco pharmacies have signed a contract with Passages Hospice to expedite...